RNAi mouse models: Revolutionizing drug discovery in vivo

被引：0
|
作者：
Premsrirut, Prem [1 ]
Dow, Lukas [2 ]
Hannon, Gregory [3 ]
Zuber, Johannes [4 ]
Lowe, Scott [2 ]
Zender, Lars [5 ]
Fellmann, Christof [1 ]
机构：
[1] Mirimus Inc, Cold Spring Harbor, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[3] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
[4] IMP, Vienna, Austria
[5] Univ Tubingen, Tubingen, Germany
来源：
MOLECULAR CANCER RESEARCH | 2014年 / 12卷
关键词：
D O I：
10.1158/1557-3125.MODORG-PR07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RNAI mouse models: revolutionizing drug discovery in vivo
    Premsrirut, Prem
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Zender, Lars
    Hannon, Gregory
    Lowe, Scott
    TRANSGENIC RESEARCH, 2014, 23 (05) : 906 - 906
  • [2] RNAi mouse models: Revolutionizing drug discovery in vivo
    Premsrirut, Prem K.
    Yoon, BoYoung
    Pesic, Marina
    Dow, Lukas E.
    Zuber, Johannes
    Lowe, Scott W.
    Hannon, Gregory J.
    Zender, Lars
    Fellmann, Christof
    CANCER RESEARCH, 2014, 74 (19)
  • [3] RNAi Mouse Models: Revolutionizing Drug Discovery In Vivo
    Premsrirut, P.
    Dow, L.
    Zuber, J.
    Hannon, G.
    Lowe, S.
    Zender, L.
    Fellmann, C.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [4] Next Generation RNAi Mouse Models for Drug Discovery and Toxicology Assessment
    Premsrirut, P.
    Fellmann, C.
    Dow, L.
    Lowe, S.
    Zuber, J.
    Hannon, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 16 - 16
  • [5] RNAi rat models for drug discovery
    Wang, Chia-Lin
    Yang, Yu-ting
    Vasileva, Ana
    Maurice, Allison
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    Premsrirut, Prem K.
    CANCER RESEARCH, 2020, 80 (16)
  • [6] RNAi and CRISPR/Cas9 Based In Vivo Models for Drug Discovery
    Premsrirut, Prem
    Wang, Chia-Lin
    Yang, Yu-ting
    Fellmann, Christof
    Dow, Lukas
    Zuber, Johannes
    Lowe, Scott
    Pesic, Marina
    Wolter, Katharina
    Zender, Lars
    BLOOD, 2017, 130
  • [7] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, Prem
    Martin, Gregory
    Dow, Lukas
    Kim, Sang Yong
    Zuber, Johannes
    Lowe, Scott
    Hannon, Greg
    TRANSGENIC RESEARCH, 2016, 25 (02) : 218 - 218
  • [8] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, Prem K.
    Martin, Gregory
    Dow, Lukas
    Kim, Sang Yong
    Zuber, Johannes
    Lowe, Scott
    Hannon, Greg
    CANCER RESEARCH, 2016, 76
  • [9] RNAi and CRISPR/Cas9-based in vivo models for drug discovery
    Premsrirut, Prem K.
    Fellmann, Christof
    CANCER RESEARCH, 2015, 75
  • [10] RNAi and CRISPR/Cas9 based in vivo models for drug discovery
    Premsrirut, P.
    Martin, G.
    Dow, L.
    Kim, S. Y.
    Zuber, J.
    Hannon, G.
    Lowe, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S208 - S208
12345